KOLBECK ROLAND WILHELM (Chief Scientific Officer) exercised options at ACLARIS THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 8/4/2026ACC: 0002076327-26-000006
Officer· Chief Scientific Officer
Since Feb 2026
-12.38K
Net shares
Net seller
$64.4K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
36.38K acquired · 48.76K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+36.38K
Price / share
—
Trade value
—
% of position
New position
8/1/2026
0.00→36.38K
Common Stock
Direct
Shares
−12.38K
Price / share
$5.20
Trade value
$64.40K
% of position
34.0%
8/1/2026
36.38K→23.99K
Total
Net shares
+23.99K
Net value
-$64.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2026 | M · Option Exercise | +36.38K | — | — | New position | 0.00 | 36.38K |
| Common Stock Direct | 8/1/2026 | F · Tax Withholding | −12.38K | $5.20 | $64.40K | 34.0% | 36.38K | 23.99K |
| Total | +23.99K | -$64.40K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
36.38K shares
Shares
−36.38K
Strike price
Held after
109.13K
Exercisable
—
8/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock36.38K shares | 8/1/2026 | M · Option Exercise | −36.38K | — | 109.13K |